Genethera Stock Probability of Future Pink Sheet Price Finishing Over 8.4E-5

GTHR Stock  USD 0.0001  0.00  0.00%   
GeneThera's future price is the expected price of GeneThera instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of GeneThera performance during a given time horizon utilizing its historical volatility. Check out GeneThera Backtesting, GeneThera Valuation, GeneThera Correlation, GeneThera Hype Analysis, GeneThera Volatility, GeneThera History as well as GeneThera Performance.
  
Please specify GeneThera's target price for which you would like GeneThera odds to be computed.

GeneThera Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of GeneThera for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for GeneThera can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
GeneThera generated a negative expected return over the last 90 days
GeneThera has some characteristics of a very speculative penny stock
Net Loss for the year was (1.01 M) with profit before overhead, payroll, taxes, and interest of 0.
GeneThera currently holds about 140.1 K in cash with (8.57 K) of positive cash flow from operations.
Roughly 18.0% of the company shares are held by company insiders

GeneThera Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of GeneThera Pink Sheet often depends not only on the future outlook of the current and potential GeneThera's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. GeneThera's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding25.4 M

GeneThera Technical Analysis

GeneThera's future price can be derived by breaking down and analyzing its technical indicators over time. GeneThera Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of GeneThera. In general, you should focus on analyzing GeneThera Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.

GeneThera Predictive Forecast Models

GeneThera's time-series forecasting models is one of many GeneThera's pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary GeneThera's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.

Things to note about GeneThera

Checking the ongoing alerts about GeneThera for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for GeneThera help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
GeneThera generated a negative expected return over the last 90 days
GeneThera has some characteristics of a very speculative penny stock
Net Loss for the year was (1.01 M) with profit before overhead, payroll, taxes, and interest of 0.
GeneThera currently holds about 140.1 K in cash with (8.57 K) of positive cash flow from operations.
Roughly 18.0% of the company shares are held by company insiders

Additional Tools for GeneThera Pink Sheet Analysis

When running GeneThera's price analysis, check to measure GeneThera's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeneThera is operating at the current time. Most of GeneThera's value examination focuses on studying past and present price action to predict the probability of GeneThera's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeneThera's price. Additionally, you may evaluate how the addition of GeneThera to your portfolios can decrease your overall portfolio volatility.